A detailed history of Advisor Group Holdings, Inc. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 27,079 shares of ME stock, worth $103,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,079
Previous 25,604 5.76%
Holding current value
$103,441
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.29 - $0.51 $427 - $752
1,475 Added 5.76%
27,079 $9,000
Q2 2024

Aug 13, 2024

SELL
$0.36 - $0.61 $1,754 - $2,973
-4,874 Reduced 15.99%
25,604 $9,000
Q1 2024

May 10, 2024

SELL
$0.4 - $0.91 $5,672 - $12,903
-14,180 Reduced 31.75%
30,478 $16,000
Q4 2023

Feb 12, 2024

SELL
$0.71 - $0.97 $12,508 - $17,088
-17,617 Reduced 28.29%
44,658 $40,000
Q3 2023

Nov 13, 2023

BUY
$0.96 - $2.01 $7,396 - $15,487
7,705 Added 14.12%
62,275 $61,000
Q2 2023

Aug 10, 2023

SELL
$1.59 - $2.29 $5,242 - $7,550
-3,297 Reduced 5.7%
54,570 $95,000
Q1 2023

May 12, 2023

BUY
$2.05 - $2.87 $31,422 - $43,991
15,328 Added 36.03%
57,867 $131,000
Q4 2022

Feb 10, 2023

SELL
$2.06 - $3.47 $1,122 - $1,891
-545 Reduced 1.26%
42,539 $91,000
Q3 2022

Nov 14, 2022

SELL
$2.6 - $5.12 $20,672 - $40,709
-7,951 Reduced 15.58%
43,084 $123,000
Q2 2022

Aug 10, 2022

SELL
$2.19 - $3.98 $7,851 - $14,268
-3,585 Reduced 6.56%
51,035 $127,000
Q1 2022

May 04, 2022

BUY
$3.28 - $7.12 $133,102 - $288,929
40,580 Added 289.03%
54,620 $210,000
Q3 2021

Nov 05, 2021

SELL
$7.29 - $11.0 $148,191 - $223,608
-20,328 Reduced 59.15%
14,040 $126,000
Q2 2021

Aug 02, 2021

BUY
$9.87 - $13.32 $339,212 - $457,781
34,368 New
34,368 $387,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.